Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ · Healthcare
Monte Rosa Therapeutics, Inc. Cash Flow 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | -22.8M | 42.0M | -43.8M | -92.5M | -59.4M | -23.1M |
| Depreciation & Amort. | — | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | 4.7M | 4.0M | 19.0M | 12.9M | 9.7M | 3.4M |
| Free Cash Flow | -27.5M | 38.0M | -62.8M | -105.4M | -69.1M | -26.4M |
| Financing Activities | ||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | — |
| Stock Buybacks | — | — | — | — | — | — |
Monte Rosa Therapeutics, Inc. Cash Flow — FAQ
Monte Rosa Therapeutics, Inc. (GLUE) cash flow over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GLUE's cash flow history?
The chart and table above show Monte Rosa Therapeutics, Inc.'s cash flow by year and by quarter, including the growth rate.